Epiwart Solution is a topical medication formulated with Salicylic Acid (16.7% w/v) and Lactic Acid (16.7% w/v), indicated for the treatment of common warts and other hyperkeratotic skin lesions. Salicylic Acid acts as a keratolytic agent, promoting the gradual exfoliation and removal of the thickened, keratinized skin layers characteristic of warts. Concurrently, Lactic Acid serves to enhance the keratolytic effect by softening the skin and improving the penetration of Salicylic Acid into the lesion. The combined action facilitates the breakdown of wart tissue, leading to lesion resolution over a course of treatment. Epiwart Solution is applied directly to the affected area once or twice daily, following proper skin cleansing and drying. Patients should avoid contact with healthy skin and mucous membranes to minimize irritation. Common adverse effects may include mild local irritation, redness, or peeling at the application site. Use is contraindicated in individuals with hypersensitivity to salicylates or lactic acid, and caution is advised in patients with diabetes or poor peripheral circulation. Epiwart Solution offers an effective, non-invasive therapeutic option for wart management when used as directed under medical supervision.